Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

10395709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Plasmid DNA delivered by injection/electroporation to the skeletal muscle can be expressed, and physiologic levels of transgene could be achieved into the circulation. Nevertheless, stabilization of naked DNA may be required and necessary in some cases, as prolonged storage at different temperatures before usage, injection into a large number of animals, etc. It is imperative that the associated compound should not be toxic to the cells (e.g. muscle cells) or cause breakage of plasmid DNA. It would be preferable for the coated DNA to have a similar or increased uptake into the target cells. Low molecular weight poly-L-glutamate compounds have all the desired properties. It was determined that mole/mole ratio DNA/PLG is the optimum concentration for gene therapeutic applications to the skeletal muscle, resulting in increased expression of the transgene, with no damage to the target tissue. Furthermore, stabilization of plasmid DNA by PLG has never been observed or described in the literature.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VGX PHARMACEUTICALS INC660 GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Attra, Heather Houston, TX 1 28
Carpenter, Robert H Bastrop, TX 37 1728
Draghia-Akli, Ruxandra Houston, TX 47 695
Hebel, Henry The Woodlands, TX 5 87
Hill, Leigh Anne Houston, TX 1 28
Kern, Douglas R The Woodlands, TX 13 332

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation